Quantitative Mapping of Specific Ventilation in the Human Lung using Proton Magnetic Resonance Imaging and Oxygen as a Contrast Agent
June 5th, 2019
Specific ventilation imaging is a functional magnetic resonance imaging technique that allows for quantification of regional specific ventilation in the human lung, using inhaled oxygen as a contrast agent. Here, we present a protocol to collect and analyze specific ventilation imaging data.
Overview
Specific Ventilation Imaging (SVI) is a qualitative lung imaging technique that enhances our understanding of respiratory physiology and disease management. This radiation-free method utilizes MRI and medical oxygen, making it safe for children and suitable for repeated studies in adults.
Key Study Components
Area of Science
- Neuroscience
- Respiratory Physiology
- Medical Imaging
Background
- SVI allows for the mapping of specific ventilation in the lungs.
- It helps identify areas affected by respiratory diseases like asthma.
- The technique is based on inhaled oxygen as a contrast agent.
- SVI is non-invasive and can be performed with standard MRI equipment.
Purpose of Study
- To improve management strategies for asthma and other respiratory conditions.
- To optimize inhalation therapies based on specific lung areas.
- To facilitate individualized therapeutic choices for patients.
Methods Used
- Utilization of MRI scanners for imaging.
- Inhalation of medical oxygen as a contrast agent.
- Analysis of regional specific ventilation data.
- Collaboration with medical professionals for protocol development.
Main Results
- Identification of lung regions most affected by asthma.
- Mapping of changes in lung function in response to therapy.
- Demonstration of SVI's potential in clinical practice.
- Contribution to personalized treatment approaches for respiratory diseases.
Conclusions
- SVI is a promising tool for understanding lung physiology.
- It may significantly enhance the management of respiratory diseases.
- The technique's safety and accessibility make it ideal for various patient populations.
Frequently Asked Questions
Executive Industry Relevance
Quantitative mapping of specific ventilation using proton MRI and oxygen contrast enables precise regional assessment of lung function, supporting early identification of ventilation heterogeneity. This capability enhances predictive confidence in respiratory disease models and informs risk-adjusted decisions in respiratory drug discovery portfolios. The method's non-invasive, radiation-free profile facilitates repeatable, longitudinal studies critical for translational research and therapeutic evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of regional lung ventilation to clarify disease mechanisms.
- Supports biological de-risking by mapping functional heterogeneity relevant to target validation.
- Provides predictive confidence for selecting disease-relevant endpoints in respiratory research.
Screening & Assay Development
- Prepares validated imaging-based assays for evaluating therapeutic interventions in lung models.
- Facilitates assay standardization and reproducibility through quantitative, voxel-level outputs.
- Enables reliable comparison of compound effects on regional lung ventilation in preclinical studies.
Translational & Preclinical Research
- Aligns imaging biomarkers with disease-relevant functional endpoints for translational continuity.
- Supports longitudinal monitoring of therapeutic response and disease progression in preclinical models.
- Provides mechanistic de-risking by correlating imaging outputs with established physiological metrics.
Pipeline & Workflow Integration
This imaging method integrates into the respiratory discovery continuum from early target validation through preclinical efficacy assessment, supporting both mechanistic studies and translational biomarker development.
- Discovery Biology: Quantitative mapping of ventilation supports hypothesis testing and pathway clarification in lung disease models.
- Screening: Imaging-based assays deliver reproducible, quantitative outputs for compound evaluation.
- Analytics: Voxel-level measurements and distribution analyses enable robust statistical comparison across conditions.
- Translational Research: Imaging outputs align with functional biomarkers for preclinical-to-clinical continuity.
- Enterprise Reuse: The protocol is adaptable for repeated, longitudinal studies across diverse respiratory models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in respiratory target validation.
- Operational Value: Standardizes imaging workflows and enables reproducible, scalable data acquisition.
- Strategic Value: Informs go/no-go decisions and optimizes resource allocation in respiratory portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of respiratory drug candidates.
Implementation Considerations
- Requires expertise in MRI operation and quantitative image analysis.
- Needs access to 1.5T MRI scanners and compatible torso coils.
- Demands cross-team standardization of imaging protocols and analysis algorithms.
- Adaptable to both single-slice and multi-slice imaging for different study designs.
- Attention to MRI safety and subject training is essential for high-quality, reproducible data.
Biopharma FAQs
Chapters in this video
0:04
Title
0:56
Subject Safety and Training
1:49
MRI Environment Preparation
3:17
Instrumentation and Subject Imaging Preparation
4:19
MR Imaging and Specific Ventilation Map Creation
6:35
Results: Representative Specific Ventilation Imaging (SVI) and Multiple Breath Washout (MBW) Analyses
7:47
Conclusion
